Page 12 - Glenmark Pharmaceuticals

Glenmark Pharma gets USFDA approval for generic lung cancer drug

Glenmark Pharmaceuticals said it has received approval from the US health regulator to market Nintedanib capsules, used in the treatment of idiopathic pulmonary fibrosis and non-small cell lung cancer

Glenmark Pharma gets US health regulator nod for inhalation product

Glenmark Pharma said it received approval from the US health regulator for Arformoterol Tartrate Inhalation Solution, used to treat conditions like chronic bronchitis and emphysema, in the US market

Glenmark Pharma releases interim data from PMS study on Favipiravir

Glenmark Pharmaceuticals announced interim data of 503 patients from its Post Marketing Surveillance (PMS) study on Favipiravir in India

Stocks to watch: GAIL, Bata India, Prestige Estates, Tata Motors, Glenmark

Reserve Bank of India granted approval for the re-appointment of Chandra Shekhar Ghosh, Managing Director & Chief Executive Officer of Bandhan Bank for a period of three years

Glenmark says interim data from study supports favipiravir's safety

A total of 13 sites across Mumbai, Bengaluru, Hyderabad, Nashik, Nagpur and Trivandrum took part in the study

Glenmark Pharmaceuticals launches Rufinamide Tablets USP, 200 mg and 400 mg

The medicines are a therapeutic equivalent of Banzel®

Drugmaker Glenmark fourth quarter net profit up 6% at Rs 233.87 crore

The rise came on account of higher sales.

Nifty Pharma index hits all-time high; Sun Pharma scales 4-year high

Since April, the Nifty Pharma index has outperformed the market by surging 15 per cent, against 1.7 per cent gain in the Nifty50 index

Glenmark Pharma hits 23-month high on Glenmark Life Sciences IPO plan

ICICI Securities believe this is a positive development for the company and will lead to value unlocking for the shareholder

Glenmark Pharma arm files paperwork for IPO with market regulator

Glenmark Pharmaceuticals on Saturday said its wholly-owned arm Glenmark Life Sciences has filed paperwork to go public

Domestic growth trajectory to remain strong for Glenmark in near term

Debt reduction key if the stock is to fetch higher valuation multiples

Glenmark gets USFDA nod for generic high blood pressure drug

Drug firmGlenmark Pharmaceuticals on Tuesday said it has received approval from the US health regulator for its generic Diltiazem Hydrochloride extended release capsules used for treatment of high blood pressure. The company has received final approval from the United States Food & Drug Administration (USFDA) for Diltiazem Hydrochloride extended-release capsules USP, in the strengths of 60 mg, 90 mg, and 120 mg, Glenmark said in a statement. The product is a generic version of Biovail Laboratories Inc's Cardizem SR extended-release capsules in the same strengths, it added. The company has been granted a competitive generic therapy (CGT) designation for these capsules, therefore, with thisapproval, Glenmark is eligible for 180 days of CGT exclusivity upon commercial marketing, the statementsaid. According to IQVIA sales data for the 12-month period ending January 2021, the Cardizem SR extended-release capsules, 60 mg, 90 mg, and 120 mg market (including brand and all available ...

Glenmark Pharma signs Rohit Sharma as brand ambassador for Candid Powder

Drug major Glenmark Pharma on Friday said it has signed cricketer Rohit Sharma as brand ambassador for its product Candid Powder.

Asset monetisation, sales uptick in US key triggers for Glenmark Pharma

The India business is expected to post double digit growth in FY22

Glenmark Pharmaceuticals net profit up 30% at Rs 248.17 cr in Dec qtr

Glenmark on Friday reported a 30.04 percent rise in its consolidated net profit to Rs 248.17 crore for the quarter ended December 2020

Sensex ends volatile trade 12 pts up; RIL jumps 6% this week, ITC down 7%

On the sectoral front, the Nifty Metal index skid 1.7 per cent, followed by the Nifty FMCG index declined 1.5 per cent

Glenmark Pharma gets USFDA approval for nervous system stimulant drug

Glenmark Pharmaceuticals Ltd has been granted final approval by the United States Food and Drug Administration (USFDA) for Amphetamine Sulfate tablets USP

Glenmark Pharma gets tentative nod from USFDA for blood thinning drug

Drug major Glenmark Pharma on Monday said it has received tentative approval from the US health regulator for anticoagulant Dabigatran Etexilate capsules

Pharma shares gain; Natco, Glenmark, Syngene, Sequent Scientific up over 5%

Patient footfalls are gaining traction in healthcare units as demand from non-Covid-19 patients is gathering pace, according to a November 25 report by CARE Ratings.

November domestic pharma sales grow just 1% after strong show last month

Oct growth rate was 9.6%; Most big corporates saw volumes drop in November